K. Cobarrubias

发表

Novel Acylguanidine-Based Inhibitor of HIV-1

I. Tietjen, J. Richard, A. Finzi, 2016, Journal of Virology.

Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation

Quanxin Long, N. Snead, A. Lee, 2018, Antimicrobial Agents and Chemotherapy.

SARS-CoV-2 RNA Quantification Using Droplet Digital RT-PCR

J. Montaner, Z. Brumme, C. Brumme, 2020, bioRxiv.

High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia

Z. Brumme, C. Brumme, M. Brockman, 2018, Viruses.

ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection.

N. Snead, X. Ye, A. Cuconati, 2018, ACS infectious diseases.

Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes

T. Ndung’u, G. Umviligihozo, E. Karita, 2020, Journal of Virology.

Extensive host immune adaptation in a concentrated North American HIV epidemic

P. Harrigan, J. Joy, S. Sanche, 2018, AIDS.

Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity

M. Carrington, Jeffrey N. Martin, P. Harrigan, 2018, Journal of Virology.

A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection

J. Carlson, S. Oka, Z. Brumme, 2016, AIDS.

The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time

A. Adimora, J. Mullins, S. Gange, 2023, Research square.

The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time

A. Adimora, J. Joy, N. Archin, 2024, Journal of virology.